References
- Keogh B A, Crystal R G. Alveolitis: The key to interstitial lung disorders. Thorax 1982; 37: 1–10
- Crystal R G, Bitterman P B, Rennard S I, Hance A J, Keogh B A. Interstitial lung diseases of unknown cause: Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984; 310: 154–166
- Snider G L. Interstitial pulmonary fibrosis–Which cell is the culprit?. Am Rev Respir Dis 1983; 127: 535–539
- Van Furth R, van Blusse Oud, Alblas A. Origin of pulmonary macrophages in mice under normal conditions and during an inflammatory reaction by heat-killed BCG. Current Probl Clin Biochem 1983; 13: 170–179
- van Blusse Oud, Alblas A, van der Linden-Shrever, van Furth R. Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intra-alveolar administration of aerosolized heat-killed BCG. Am Rev Respir Dis 1983; 128: 276–281
- Evans M J, Shami S G, Martinez L A. Enhanced proliferation of pulmonary alveolar macrophages after carbon instillation in mice depleted of blood monocytes by Strontium-89. Lab Invest 1986; 54: 154–159
- Oghiso Y, Kubota Y, Takahashi S, Sato H. Effect of 89Sr-induced monocytopenia on splenic and pulmonary alveolar macrophage populations in a normal steady state. J Radiat Res 1988; 29: 189–202
- Bitterman P B, Saltzman L E, Adelberg S, Ferrans V J, Crystal R G. Alveolar macrophage replication: One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest 1984; 74: 460–469
- Snider G L, Hayes J A, Korthy A L. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: Pathology and stereology. Am Rev Respir Dis 1978; 117: 1099–1108
- Thrall R S, McCormick J R, Jack R M, McReynolds R A, Ward P A. Bleomycin-induced pulmonary fibrosis in the rat: Inhibition by indomethacin. Am J Pathol 1979; 95: 117–130
- Schrier D J, Kunkel R G, Phan S H. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 1983; 127: 63–66
- Thrall R S, Barton R W, D'Amato D A, Sulavik S B. Differential cellular analysis of bronchoalveolar lavage fluid obtained at various stages during the development of bleomycin-induced pulmonary fibrosis in the rat. Am Rev Respir Dis 1982; 126: 488–492
- Jacobson L O, Simmons E L, Block M H. The effect of splenectomy on the toxicity of SR89 to the hematopoietic system of mice. J Lab Clin Med 1949; 34: 1640–1655
- Sawyer R T, Strausbauch P H, Volkman A. Resident macrophage proliferation in mice depleted of blood monocytes by Strontium-89. Lab Invest 1982; 46: 165–170
- Pickrell J A, Harris D V, Benjamin S A, Cuddihy R G, Pfleger R C, Mauderly J L. Pulmonary collagen metabolism after lung injury from inhaled UY in fused clay particles. Exp Mol Pathol 1976; 25: 70–81
- Grant R A. Estimation of hydroxyproline by the AutoAnalyser. J Clin Pathol 1964; 17: 685–686
- Zoller M, Matzku S. Rat natural killer (NK) cells are not bone marrow dependent. Immunobiology 1983; 165: 121–131
- Giri S N, Hyde D M, Nakashima J M. Analysis of bronchoalveolar lavage fluid from bleomycin-induced pulmonary fibrosis in hamsters. Toxicol Pathol 1986; 14: 149–157
- Thrall R S, Banon R W. A comparison of lymphocyte populations in lung tissue and in bronchoalveolar lavage fluid of rats in various times during the development of bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 1984; 129: 279–283
- Shen A S, Haslett C, Feldsien D C, Henson P M, Cherniack R M. The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. Am Rev Respir Dis 1988; 137: 564–571
- Moseley P L, Shasby D M, Brady M, Hunninghake G W. Lung parenchymal injury induced by bleomycin. Am Rev Respir Dis 1984; 130: 1082–1086
- Tate R M, Repine J E. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1983; 128: 552–559
- White D A, Kris M G, Stover D E. Bronchoalveolar lavage cell populations in bleomycin lung toxicity. Thorax 1987; 42: 551–552
- Thrall R S, Phan S H, McCormick J R, Ward P A. The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats. Am J Pathol 1981; 105: 76–81
- Clark J G, Kuhn C. Bleomycin-induced pulmonary fibrosis in hamsters: Effect of neutrophil depletion on lung collagen synthesis. Am Rev Respir Dis 1982; 126: 737–739
- Phan S H, Schrier D, McGarry B. Effect of beige mutation on bleomycin-induced pulmonary fibrosis in mice. Am Rev Respir Dis 1983; 127: 456–459
- Schrier D J, Phan S H, McGarry B M. The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 1983; 127: 614–617
- Schrier D J, Phan S H. Modulation of bleomycin-induced pulmonary fibrosis in the BALB/c mouse by cyclophosphamide-sensitive T cells. Am J Pathol 1984; 116: 270–278
- Rennard S I, Hunninghake S W, Bitterman P B, Crystal R G. Production of fibro-nectin by the human alveolar macrophage: Mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung disease. Proc Nat Acad Sci USA 1981; 78: 7147–7151
- Bitterman P B, Adelberg S, Crystal R G. Mechanisms of pulmonary fibrosis: Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest 1983; 72: 1801–1813
- Phan S H, Kunkel S L. Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguiaretic acid. Am J Pathol 1986; 124: 343–352
- Fels A OS, Cohn Z A. The alveolar macrophage. J Appl Physiol 1986; 60: 353–369
- Clark J G, Greenberg J. Modulation of the effects of alveolar macrophages on lung fibroblast collagen production rate. Am Rev Respir Dis 1987; 135: 52–56
- Adamson I YR, Bowden D H. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 1974; 77: 185–198
- Ross R, Raines E W, Bowen-Pope D F. The biology of platelet-derived growth factor. Cell 1986; 46: 155–169